Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 07 December, 2009 and appeared in  Issue 499Cardiovascular Health

Model May Help End-of-Life Planning for Dialysis Patients

Researchers in Massachusetts say they have developed a model to assess the life-expectancy of kidney disease patients on dialysis that could help guide discussions about end-of-life care

Advertisement

The model, which combines scores based on five simple factors, accurately predicted the likelihood of dying within six months in 87% of cases (95% CI 0.82 to 0.92), according to a published study.

The model was validated in a second cohort of patients whose six-month mortality risk was predicted accurately 80% of the time (95% CI 0.73 to 0.88).

Michael J. Germain, MD, of Baystate Medical Center in Springfield, and colleagues wrote, "The integrated prognostic model lends itself to risk stratification of patients, it is more specific and sensitive than any of its components ... and it seems to be a considerable improvement over other existing instruments at predicting survival in the dialysis population."

Unwilling to make patients feel hopeless, and lacking accurate tools for predicting life expectancy, nephrologists rarely have discussions with patients about prognosis and end-of-life care, the authors wrote. However, the Renal Physicians Association and American Society of Nephrology explicitly recommend doctors have such discussions.

"Clinically, this is necessary to allow patients and families to be informed of prognosis and provided with the opportunity to engage in meaningful advance-care planning discussions," Germain and colleagues wrote.

"Depending on patient symptoms and preferences, the identification of a poor prognosis can lead to a palliative care consultation and hospice referral."

To that end, researchers developed a model that relies on reviewing a patient's chart for actuarial data and on the doctors' response to a so-called "surprise question," or SQ: "Would I be surprised if this patient died within the next six months?"

A negative answer suggested a lower life expectancy, as did older age, decreased serum albumin, presence of dementia, and presence of peripheral vascular disease. The six-month duration was chosen because it is the maximum life expectancy requirement for hospice eligibility.

The researchers developed the model using prospective data collected between July 2006 and September 2007 from a study 512 kidney disease patients on dialysis at five clinics in western Massachusetts. This allowed them to determine which factors best predicted life expectancy.

They found that the following factors put dialysis patients at increased risk of early mortality:

  • Older age (hazard ratio [HR] for a 10-year increase 1.35; 95% CI 1.17 to 1.57)
  • Dementia (HR 1.88; 95% CI 1.24 to 2.84)
  • Peripheral vascular disease (HR 2.24; 95% CI 1.11 to 4.48)
  • Decreased albumin (HR for a 1-U increase 0.27; 95% CI 0.15 to 0.50)
  • Answering "No" to the SQ (HR 2.71; 95% CI 1.76 to 4.17)

When combining these factors to predict short-term life expectancy, the model was 87% accurate.

Once they had identified these five factors, the researchers tested the accuracy of their model between September and October of 2008 on 514 kidney disease patients on dialysis at eight New England clinics. In this group of patients, the model was 80% accurate.

The authors cautioned that their study was limited to patients living in New England, and that future studies are need to determine if the predictive model they developed is accurate in other regions and populations.

They also noted that the two groups of patients they studied had different proportions of patients on dialysis for longer than three months. Also, while the percentage of cases with missing information was low, there were some cases of missing data for nearly all the variables.

"Despite all of these considerations, the integrated prognostic model satisfactorily predicted mortality in the validation cohort," they concluded.

Published online in the Clinical Journal of the American Society of Nephrology, Dec 2009

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 07 December, 2009 and appeared in  Issue 499Cardiovascular Health

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control